// App-Quantinova.ai

PB1098 : Results in Patients with Heparin Induced Thrombocytopenia or Vaccine Induced Thrombocytopenia with Thrombosis Confirm the Unsuitability of Using APTT Ratio to Monitor Argatroban Therapy

Researchers

Presenter

  • S. Platton

Principal Investigators

  • M. Dave

  • N. Yartey

  • P. MacCallum

Medical Centers

  • Barts Health NHS Trust, London, United Kingdom

  • Stem Cell Laboratory, Royal London Hospital, Barts Health NHS Trust, London, United Kingdom

  • Department of Haematology, Royal London Hospital, Barts Health NHS Trust, London, England, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Pulmonary/Respiratory Diseases

  • Blood/haematological Diseases

Disease

  • Thrombocytopenia

  • Venous thrombosis

Biomarkers

  • Activated partial thromboplastin time

Drug/Treatment

  • Argatroban

  • Evithrom

  • Heparin

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved